- Report
- January 2026
- 187 Pages
Global
From €3458EUR$3,939USD£3,008GBP
- Report
- November 2025
- 184 Pages
Global
From €3458EUR$3,939USD£3,008GBP
- Report
- October 2025
- 183 Pages
Global
From €3458EUR$3,939USD£3,008GBP
- Report
- May 2025
- 200 Pages
Global
From €4169EUR$4,750USD£3,627GBP
- Report
- December 2025
- 250 Pages
Global
From €3941EUR$4,490USD£3,429GBP
- Report
- September 2025
- 250 Pages
Global
From €3941EUR$4,490USD£3,429GBP
- Report
- September 2025
- 250 Pages
Global
From €3941EUR$4,490USD£3,429GBP
- Report
- September 2025
- 250 Pages
Global
From €3941EUR$4,490USD£3,429GBP
- Report
- February 2026
- 467 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 468 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 390 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 266 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 573 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 372 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 279 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 578 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 360 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 372 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 367 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 285 Pages
Global
From €5135EUR$5,850USD£4,467GBP

The Vaccine Manufacturing market is a subset of the biopharmaceutical industry, which focuses on the development and production of vaccines. Vaccines are biological products that are used to prevent and treat infectious diseases. Vaccine manufacturing involves the production of active ingredients, such as antigens, as well as the formulation and packaging of the final product. Vaccine manufacturers must adhere to strict regulatory standards to ensure the safety and efficacy of their products.
The Vaccine Manufacturing market is highly competitive, with a number of large pharmaceutical companies and biotechnology firms competing for market share. Companies in the market include Merck & Co., GlaxoSmithKline, Sanofi, Pfizer, Johnson & Johnson, and Novavax. Show Less Read more